1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2016

Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 107 pages

Includes 3 FREE quarterly updates

BMI View: A prolonged period of subdued oil prices may see Saudi Arabia cut back on high value drugspending. While public spending on healthcare will remain high as a result of the sensitive nature of thesector and its political importance, governments will enforce cost-containment measures, including pricecuts on medicines and private sector engagement, to limit healthcare spending.

Headline Expenditure Projections

- Pharmaceuticals: SAR28.4bn (USD7.6bn) in 2014 to SAR31.8bn (USD8.5bn) in 2015; +11.9% in bothlocal currency and US dollar terms. Forecast unchanged from Q415.

- Healthcare: SAR103.7bn (USD27.7bn) in 2014 to SAR119.8bn (USD31.9bn) in 2015; +15.5% in bothlocal currency and US dollar terms. Forecast in line with Q415.

Table Of Contents

Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Saudi Arabia 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019) 22
OTC Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2011-2019) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2013-2019) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2013-2019) 27
Industry Risk Reward Index 28
Middle East and Africa Risk/Reward Index - Q1 2016 28
Saudi Arabia Risk/Reward Index 36
Rewards 36
Risks 36
Market Overview 38
Healthcare Sector 39
Table: Healthcare Resources (Saudi Arabia 2009-2014) 48
Table: Healthcare Personnel (Saudi Arabia 2009-2014) 48
Table: Healthcare Activity (Saudi Arabia 2009-2014) 49
Research and Development 50
Biotechnology 51
Clinical Trials 52
Epidemiology 53
Regulatory Review 56
Intellectual Property Issues 60
Pricing Regime 63
Reimbursement Regime 65
Competitive Landscape 67
Research-Based Industry 67
Table: Multinational Pharmaceutical Company Activity 71
Pharmaceutical Distribution 72
Pharmaceutical Retail Sector 74
Company Profile 75
GlaxoSmithKline 75
Hikma Pharmaceuticals Plc 78
Jamjoom Pharma 80
Saudi Arabian Japanese Pharmaceutical (SAJA) 83
Sanofi 85
SPIMACO 88
TABUK Pharmaceutical Manufacturing 92
Demographic Forecast 96
Demographic Outlook 96
Table: Population Headline Indicators (Saudi Arabia 1990-2025) 97
Table: Key Population Ratios (Saudi Arabia 1990-2025) 97
Table: Urban/Rural Population and Life Expectancy (Saudi Arabia 1990-2025) 98
Table: Population By Age Group (Saudi Arabia 1990-2025) 98
Table: Population By Age Group % (Saudi Arabia 1990-2025) 99
Glossary 101
Methodology 103
Pharmaceutical Expenditure Forecast Model 103
Healthcare Expenditure Forecast Model 103
Notes On Methodology 104
Risk/Reward Index Methodology 105
Index Overview 106
Table: Pharmaceutical Risk/Reward Index Indicators 106
Indicator Weightings 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.